1O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angoigenesis and tumor growth. Cell, 1997,88:11721-11726.
2Dielius J, Larsson H, Sasaki T, et al. Endostatin-induced tyrosine kinase signaling through the Shb adsptor protein regulates endothelial cell apoptosis. Blood, 2000,95:3403-3411.
3Boehm T, Folkrnan J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature, 1997,390 : 404-407.
4Lai CM, Lai YK, Rakoczy PE. Adenovirus and adeno-associated virus vectors. DNA Cell Biol,2002,21:895-913.
5Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer ] Clin 2009; 59: 225-249 [PMID: 19474385 DOI: 10.3322/caac.20006].
6Heinemann V, Boeck S, Hinke A, Labianca R, Lou- vet C. Meta-analysis of randomized trials: evalua- tion of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic can- cer. BMC Cancer 2008; 8:82 [PMID: 18373843 DOI: 10.1186/1471-2407-8-82].
7Sultana A, Tudur Smith C, Cunningham D, Starling N, Neoptolemos JP, Ghaneh P. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses. Br ] Cancer 2008; 99:6-13 [PMID: 18577990 DOI: 10.1038/sj.bjc.6604436].
8Stathis A, Moore MJ. Advanced pancreatic carci- noma: current treatment and future challenges. Nat Rev Clin Oncol 2010; 7:163-172 [PMID: 20101258 DOI: 10.1038/nrclinonc.2009.236].
9Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg 2007; 246:173-180 [PMID: 17667493 DOI: 10.1097/ SLA.0b013e3180691579].
